SMR Peptide Antagonizes Mortalin Promoted Release of Extracellular Vesicles and Affects Mortalin Protection From Complement-Dependent Cytotoxicity in Breast Cancer Cells and Leukemia Cells
Oncotarget - United States
doi 10.18632/oncotarget.27138
Full Text
Open PDFAbstract
Available in full text
Categories
Date
September 10, 2019
Authors
Publisher
Impact Journals, LLC